Fines for advertising cannabis and other prescription medicines
Multiple fines for unlawful advertising of medicinal cannabis and other prescription medicines have been issued this year by the Therapeutic Goods Administration (TGA). The fines include $132,000, $742,500 and $82,500 for companies, and $6,600, $13,320 and $9,900 for individuals. In October 2023, in Federal Court proceedings, the TGA obtained a combined $5 million penalty against a company and a Director for unlawfully advertising nicotine vaping products.
